Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas (Q42816041)

7 November 2017

title

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas (English)

1 reference

7 November 2017

0 references

1 reference

7 November 2017

Anne-Marie Mes-Masson

1 reference

Australian Ovarian Cancer Study Group

7 November 2017

object named as

Australian Ovarian Cancer Study Group

1 reference

7 November 2017

Michael S Anglesio

0 references

Leah M Prentice

1 reference

7 November 2017

Jessica N McAlpine

1 reference

7 November 2017

David G Huntsman

1 reference

7 November 2017

Steve E Kalloger

1 reference

7 November 2017

C Blake Gilks

1 reference

7 November 2017

Sohrab P Shah

1 reference

7 November 2017

Janine Senz

1 reference

7 November 2017

Melissa K McConechy

1 reference

7 November 2017

Alireza Heravi-Moussavi

object named as

Alireza Heravi-Moussavi

1 reference

7 November 2017

Christine Chow

1 reference

7 November 2017

Janice S Kwon

1 reference

7 November 2017

Winnie Yang

1 reference

7 November 2017

Mark S Carey

1 reference

7 November 2017

Niki Boyd

1 reference

7 November 2017

publication date

7 March 2011

1 reference

7 November 2017

1 reference

7 November 2017

volume

223

1 reference

7 November 2017

1 reference

7 November 2017

page(s)

567-573

1 reference

describes a project that uses

7 November 2017

OCCC33

0 references

OLGS1

0 references

cites work

Cancer statistics, 2010

1 reference

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

21 January 2018

1 reference

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.

21 January 2018

1 reference

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

21 January 2018

1 reference

Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma

21 January 2018

1 reference

Molecular profiling of endometrial malignancies

21 January 2018

1 reference

Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme

21 January 2018

1 reference

PP2A: the expected tumor suppressor

21 January 2018

1 reference

alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure

21 January 2018

1 reference

Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution

21 January 2018

1 reference

The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs

21 January 2018

1 reference

Structure of the protein phosphatase 2A holoenzyme

21 January 2018

1 reference

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene

21 January 2018

1 reference

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

21 January 2018

1 reference

Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases

21 January 2018

1 reference

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

21 January 2018

1 reference

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

21 January 2018

1 reference

Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?

21 January 2018

1 reference

Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A.

21 January 2018

1 reference

Association of protein phosphatase 2A with polyoma virus medium tumor antigen

21 January 2018

1 reference

Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control

21 January 2018

1 reference

Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics

21 January 2018

1 reference

PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation.

21 January 2018

1 reference

Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit

21 January 2018

1 reference

SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells.

21 January 2018

1 reference

Alterations of the PPP2R1B gene in human lung and colon cancer

21 January 2018

1 reference

Mutation ofFOXL2in Granulosa-Cell Tumors of the Ovary

21 January 2018

1 reference

The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

21 January 2018

1 reference

Determinants of protein function revealed by combinatorial entropy optimization

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.2848

1 reference

7 November 2017

1 reference